CEO Aaron Schacht speaks at Ferment conference

Each spring, Ginkgo Bioworks holds its annual Ferment conference showcasing the most exciting new ideas in synthetic biology. This year, BiomEdit CEO Aaron Schacht was asked to participate in the “Application Lightning Round” and give a 5 minute presentation about how the company is using synthetic biology to solve some of the most intractable problems […]

How it Works: Pipeline Project BE-101

BE-101 – a probiotic vectored antibody (pvAb™) biological specifically engineered to combat the damaging effects of necrotic enteritis in broiler chickens As BiomEdit’s newest project to enter pivotal development, BE-101 represents one of our most advanced and promising assets. Its demonstrated successes, both in vitro and in vivo, validate our approach and the suitability of […]